Results 231 to 240 of about 383,796 (264)
Some of the next articles are maybe not open access.

Plasma globotriaosylsphingosine as a biomarker of Fabry disease

Molecular Genetics and Metabolism, 2010
Fabry disease is an X-linked genetic disorder caused by a deficiency of alpha-galactosidase A (GLA) activity. As enzyme replacement therapy (ERT) involving recombinant GLAs has been introduced for this disease, a useful biomarker for diagnosis and monitoring of therapy has been strongly required.
Tadayasu, Togawa   +9 more
openaire   +2 more sources

Mining the plasma proteome for cancer biomarkers

Nature, 2008
Systematic searches for plasma proteins that are biological indicators, or biomarkers, for cancer are underway. The difficulties caused by the complexity of biological-fluid proteomes and tissue proteomes (which contribute proteins to plasma) and by the extensive heterogeneity among diseases, subjects and levels of sample procurement are gradually ...
Samir M, Hanash   +2 more
openaire   +2 more sources

Plasma metabolomics reveals biomarkers of the atherosclerosis

Journal of Separation Science, 2010
AbstractAtherosclerotic cardiovascular disease remains the leading cause of morbidity and mortality in industrialized societies. The lack of metabolite biomarkers has impeded the clinical diagnosis of atherosclerosis so far. In this study, stable atherosclerosis patients (n=16) and age‐ and sex‐matched non‐atherosclerosis healthy subjects (n=28) were ...
Chen, Xi   +9 more
openaire   +3 more sources

Plasma proteins as biomarkers of the aging process

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1995
This study was designed to characterize the rat serum proteins as biomarkers of the normal aging process. Crossed immunoelectrophoresis or electroimmunodiffusion quantitation of proteins was performed in rats aged 6, 12, 24, and 30 mo. Selection of healthy animals was based on confrontation of crossed immunoelectrophoresis patterns with those of ...
R, Vranckx   +6 more
openaire   +2 more sources

Plasma biomarkers for Alzheimer’s

C&EN Global Enterprise, 2018
Protein clumps called amyloids accumulate in the brains of people with Alzheimer’s disease. The current methods for detecting amyloids—positron emission tomography (PET) imaging of the brain and measurement of the clumping protein amyloid-β in cerebrospinal fluid—are expensive and invasive.
openaire   +1 more source

Optimization of SELDI for Biomarker Detection in Plasma

2010
The surface-enhanced laser desorption ionization (SELDI) technology is a promising approach not only for the research of biomarkers in the blood of patients in clinical applications but also in preclinical studies to assess the drug-induced toxicities.
Jean-Francois, Léonard   +2 more
openaire   +2 more sources

Plasma proteomic pattern as biomarkers for ovarian cancer

International Journal of Gynecological Cancer, 2006
Early detection of ovarian cancer remains a challenge. Pathologic changes within an organ might be reflected in proteomic patterns in serum or plasma. The objective of this study was to identify new plasma biomarkers in ovarian cancer patients using mass spectrometry (MS) protein profiling and artificial intelligence.
Y-W, Lin   +6 more
openaire   +2 more sources

Plasma Fibrinogen as a Biomarker in Gynecologic Cancers

Personalized Medicine, 2011
Coagulation & cancer Coagulation and cancer progression have been demonstrated to be closely related. For example, tumor cells produce procoagulant factors such as fibrinogen [1], which in turn promotes tumor angiogenesis by interacting with growth factors such as FGF-2 and VEGF [2,3]. In addition, fibrinogen and fibrin facilitate binding between tumor
openaire   +2 more sources

Plasma microRNAs as biomarkers in hereditary angioedema

Annals of Allergy, Asthma & Immunology
Hereditary angioedema (HAE) is an autosomal dominant disease with variable expression. In some families with identical genetic abnormalities, the expression can range from several attacks per month to no attacks at all. It is hypothesized that post-transcriptional gene regulation accounts for the variable expression of the disease.To identify candidate
Timothy, Craig   +2 more
openaire   +2 more sources

Proanp and Probnp in Plasma As Biomarkers of Heart Failure

Biomarkers in Medicine, 2019
Aim: To compare the measurement of proANP and proBNP in plasma for the diagnosis of heart failure. Methods: In the PubMed search, a process of combining subject headings and terms regarding comparison of natriuretic peptides (proANP and proBNP) was performed.
Davidovski, Filip Soeskov   +1 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy